Jointown Pharmaceutical Group Co Ltd Total Liabilities
Jointown Pharmaceutical Group Co Ltd total liabilities. Based on the latest financial reports, Jointown Pharmaceutical Group Co Ltd (600998) has total liabilities worth CN¥77.21 Billion CNY (≈ $11.30 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Jointown Pharmaceutical Group Co Ltd (600998) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Jointown Pharmaceutical Group Co Ltd (2007–2024)
Total liabilities of Jointown Pharmaceutical Group Co Ltd from 2007 to 2024. This chart illustrates how Jointown Pharmaceutical Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of Jointown Pharmaceutical Group Co Ltd to see how much of total assets are deployed in long-term investments.
Jointown Pharmaceutical Group Co Ltd Competitors by Total Liabilities
The table below lists competitors of Jointown Pharmaceutical Group Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bread Financial Holdings, Inc.
NYSE:BFH
|
USA | $19.09 Billion |
|
Centre Testing Intl Shenzhen
SHE:300012
|
China | CN¥2.34 Billion |
|
Karur Vysya Bank Limited
NSE:KARURVYSYA
|
India | Rs1.29 Trillion |
|
Wuchan Zhongda Group Co Ltd
SHG:600704
|
China | CN¥164.05 Billion |
|
Sonae SGPS SA
LS:SON
|
Portugal | €7.41 Billion |
|
BancFirst Corporation
NASDAQ:BANF
|
USA | $8.67 Billion |
|
GPGI, Inc.
NYSE:GPGI
|
USA | $297.80 Million |
|
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521
|
China | CN¥11.90 Billion |
Liability Composition Analysis (2007–2024)
This chart breaks down Jointown Pharmaceutical Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 600998 total assets.
Liquidity & Leverage Metrics
Jointown Pharmaceutical Group Co Ltd Total Liabilities Ratios Explained
Jointown Pharmaceutical Group Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.73 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jointown Pharmaceutical Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jointown Pharmaceutical Group Co Ltd (2007–2024)
The table below shows the annual total liabilities of Jointown Pharmaceutical Group Co Ltd from 2007 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥68.80 Billion ≈ $10.07 Billion |
+8.67% |
| 2023-12-31 | CN¥63.31 Billion ≈ $9.26 Billion |
-0.43% |
| 2022-12-31 | CN¥63.59 Billion ≈ $9.30 Billion |
+8.02% |
| 2021-12-31 | CN¥58.86 Billion ≈ $8.61 Billion |
+6.62% |
| 2020-12-31 | CN¥55.21 Billion ≈ $8.08 Billion |
+12.25% |
| 2019-12-31 | CN¥49.18 Billion ≈ $7.20 Billion |
+6.24% |
| 2018-12-31 | CN¥46.29 Billion ≈ $6.77 Billion |
+42.39% |
| 2017-12-31 | CN¥32.51 Billion ≈ $4.76 Billion |
+21.68% |
| 2016-12-31 | CN¥26.72 Billion ≈ $3.91 Billion |
+17.50% |
| 2015-12-31 | CN¥22.74 Billion ≈ $3.33 Billion |
+41.79% |
| 2014-12-31 | CN¥16.04 Billion ≈ $2.35 Billion |
+20.98% |
| 2013-12-31 | CN¥13.26 Billion ≈ $1.94 Billion |
+32.99% |
| 2012-12-31 | CN¥9.97 Billion ≈ $1.46 Billion |
+32.29% |
| 2011-12-31 | CN¥7.54 Billion ≈ $1.10 Billion |
+82.88% |
| 2010-12-31 | CN¥4.12 Billion ≈ $602.92 Million |
-25.02% |
| 2009-12-31 | CN¥5.50 Billion ≈ $804.09 Million |
+29.55% |
| 2008-12-31 | CN¥4.24 Billion ≈ $620.69 Million |
+34.95% |
| 2007-12-31 | CN¥3.14 Billion ≈ $459.94 Million |
-- |
About Jointown Pharmaceutical Group Co Ltd
Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution and supply chain business in China and internationally. It is also involved in general agency brand promotion; pharmaceutical industrial self-production and OEM; and pharmaceutical new retail and ten-thousand store alliance plan businesses. In addition, the company provides medical health and technology value-added serv… Read more